97 related articles for article (PubMed ID: 6399429)
1. [Serum beta 2 microglobulin concentration in patients with multiple myeloma].
Mendek-Czajkowska E
Acta Haematol Pol; 1984; 15(3-4):161-5. PubMed ID: 6399429
[No Abstract] [Full Text] [Related]
2. [Prognostic significance of beta-2-microglobulin in multiple myeloma].
Podol'tseva EI; Morozova EV; Almazov VA
Vopr Onkol; 1996; 42(4):32-5. PubMed ID: 8928455
[TBL] [Abstract][Full Text] [Related]
3. [Assay of serum beta 2-microglobulin in patients with malignant hematologic diseases and its clinical significance].
Zhong M; Liu W
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):277-8. PubMed ID: 9868137
[No Abstract] [Full Text] [Related]
4. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
[TBL] [Abstract][Full Text] [Related]
5. Unexpected normal serum beta-microglobulin (B2M) levels in multiple myeloma.
Bataille R; Grenier J; Sany J
Anticancer Res; 1987; 7(3 Pt B):513-5. PubMed ID: 3307602
[TBL] [Abstract][Full Text] [Related]
6. Serum beta 2 microglobulin in solitary plasmocytomata.
Avilés A; Huerta J; Zepeda G; Díaz-Maqueo JC
Blood; 1990 Oct; 76(8):1663. PubMed ID: 2207335
[No Abstract] [Full Text] [Related]
7. [Serum levels of beta 2-microglobulin in malignant hemopathies].
López Fernández A; Cuesta B; Rocha E
Sangre (Barc); 1985; 30(3):320-9. PubMed ID: 3898421
[No Abstract] [Full Text] [Related]
8. [Clinical features and status in multiple myeloma].
Sawamura M; Murakami H; Ogawara H; Tsuchiya J
Rinsho Ketsueki; 1993 Apr; 34(4):444-9. PubMed ID: 8510331
[TBL] [Abstract][Full Text] [Related]
9. Beta-2-microglobulin in multiple myeloma.
Musarurwa C; Matarira HT
Cent Afr J Med; 2004; 50(1-2):19-20. PubMed ID: 15490720
[No Abstract] [Full Text] [Related]
10. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
[No Abstract] [Full Text] [Related]
11. International Staging System required standardization of biochemical laboratory testing in multiple myeloma.
Tichý M; Maisnar V; Palicka V; Friedecký B; Vávrová J; Novotná H; Cermáková Z; Dastych M; Cechák P; Vogtová D; Jarolímková E; Benáková H; Hachová L; Bezdícková D; Kouril F; Zábranská EA; Zenková J; Slabý P; Scudla V; Gregora E; Spicka I; Straub J; Schützova M; Hájek R
Neoplasma; 2006; 53(6):492-4. PubMed ID: 17167717
[TBL] [Abstract][Full Text] [Related]
12. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.
Leleu X; Le Friec G; Facon T; Amiot L; Fauchet R; Hennache B; Coiteux V; Yakoub-Agha I; Dubucquoi S; Avet-Loiseau H; Mathiot C; Bataille R; Mary JY;
Clin Cancer Res; 2005 Oct; 11(20):7297-303. PubMed ID: 16243800
[TBL] [Abstract][Full Text] [Related]
13. Type III procollagen N-peptide correlates with beta-2-microglobulin in myelomatosis.
Hasselbalch HC; Bjerrum OW; Junker P
Clin Lab Haematol; 1995 Sep; 17(3):237-41. PubMed ID: 8719897
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of some biochemical and immunologic factors in the management of multiple myeloma].
Abdulkadyrov KM; Stel'mashenko LV; Bessmel'tsev SS; Lubo-Lesnichenko IF; Sel'tser AV; Rozanova OE; Gubarenko NK; Bubnova LN; Mnuskina MM; Zhuchikhina AA; Blinov MN; Gritskevich NL
Vopr Onkol; 1998; 44(3):304-9. PubMed ID: 9695777
[TBL] [Abstract][Full Text] [Related]
15. Serum beta-2-microglobulin in patients with multiple myeloma treated with alpha interferon.
Murakami H; Ogawara H; Morita K; Saitoh T; Matsushima T; Tamura J; Sawamura M; Karasawa M; Miyawaki S; Schimano S; Satoh S; Tsuchiya J
J Med; 1997; 28(5-6):311-8. PubMed ID: 9604789
[TBL] [Abstract][Full Text] [Related]
16. Diurnal variations of serum beta 2-microglobulin in multiple myeloma.
Pasqualetti P; Casale R; Colantonio D; Collacciani A; Natali G
Life Sci; 1991; 49(6):435-8. PubMed ID: 1865748
[TBL] [Abstract][Full Text] [Related]
17. [Beta 2-microglobulin in lymphoproliferative disorders].
Leoni P; Sprovieri G; Recchioni A; Orrico C; Olivieri A
G Clin Med; 1983; 64(9-10):315-25. PubMed ID: 6363188
[No Abstract] [Full Text] [Related]
18. [Prognostic value of serum beta2-microglobulin in multiple myeloma].
Bettini R; Redaelli S; Maino C; Bertuol S; Costantini C; Lazzarini A; Brivio L; Gorini M
Recenti Prog Med; 2005 Feb; 96(2):81-6. PubMed ID: 15844767
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in multiple myeloma: role of beta 2-microglobulin and thymidine kinase.
Diem H; Fateh-Moghadam A; Lamerz R
Clin Investig; 1993 Nov; 71(11):918-23. PubMed ID: 8312685
[TBL] [Abstract][Full Text] [Related]
20. Beta 2-microglobulin in monoclonal gammopathies.
Vercelli D; Cozzolino F; Becucci A; Di Guglielmo R
Nouv Rev Fr Hematol (1978); 1982; 24(2):85-8. PubMed ID: 6180380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
